93 related articles for article (PubMed ID: 31885739)
1. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
[TBL] [Abstract][Full Text] [Related]
3. High expression of ANRIL correlated with the poor prognosis in patients with cancer: A meta-analysis.
Liu Y; Zhu L; Zhao W; Zhou Y; Shao S
Medicine (Baltimore); 2022 Sep; 101(36):e30531. PubMed ID: 36086708
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of LncRNA BLACAT1 overexpression in various tumors: a meta-analysis.
Yan X; Zhang N; Wang G; Wang J
Front Genet; 2024; 15():1362420. PubMed ID: 38601076
[TBL] [Abstract][Full Text] [Related]
5. Relationship between LINC00341 expression and cancer prognosis.
Liao M; Li B; Zhang S; Liu Q; Liao W; Xie W; Zhang Y
Oncotarget; 2017 Feb; 8(9):15283-15293. PubMed ID: 28146429
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of
Zhou J; Xu N; Kang Y; Wang W; Chen F
Transl Cancer Res; 2020 May; 9(5):3426-3434. PubMed ID: 35117708
[TBL] [Abstract][Full Text] [Related]
7. Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion.
Shi P; Liu Y; Zhang M; Yang J; Jing S; Yang D; Liu F; Wu Y; Shi H; Geng C
Transl Cancer Res; 2021 Sep; 10(9):4158-4168. PubMed ID: 35116712
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA GHET1 promotes thyroid cancer cell proliferation and invasion.
Liu Y; Shi P; Fang H; Zhao Z; Yang F; Zhang J; Jing S; Geng C
Transl Cancer Res; 2021 Sep; 10(9):4148-4157. PubMed ID: 35116711
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort Study.
Jiao L; Wei J; Ye J; Zhang C
Dis Markers; 2021; 2021():9508702. PubMed ID: 33747258
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
Yuan Q; Gao C; Lai XD; Chen LY; Lai TB
Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients.
Mei JC; Yan G; Mei SQ
Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Clinicopathological Significance of Long Noncoding RNA GHET1 in Human Solid Tumors: a Meta-Analysis.
Zeng L; Yang M; Gao D; Li N
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658414
[TBL] [Abstract][Full Text] [Related]
15. Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis.
Zhang Y; Tian Q; Huang S; Wang Q; Wu H; Dong Q; Chen X
BMC Cancer; 2022 Jan; 22(1):10. PubMed ID: 34979987
[TBL] [Abstract][Full Text] [Related]
16. The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis.
Song J; Chen X; Tian Q; Lun L; Wang Q; Wang H; Li X; Liu Z; Tian L; Jing X; Zhang Y; Tian R
Dis Markers; 2019; 2019():5824190. PubMed ID: 31885739
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis.
Dong B; Chen X; Zhang Y; Zhu C; Dong Q
BMC Cancer; 2019 Aug; 19(1):780. PubMed ID: 31391030
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
